Polymeric Composites Having Oriented Nanomaterials and Methods of Making the Same
US-2015047968-A1 · Feb 19, 2015 · US
US10688442B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10688442-B2 |
| Application number | US-201615741498-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 5, 2016 |
| Priority date | Jul 2, 2015 |
| Publication date | Jun 23, 2020 |
| Grant date | Jun 23, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure describes a method of forming highly ordered membrane protein crystals. The forming process is done in the presence of a magnetic field to exploit the diamagnetic anisotropy of the membrane protein. Further described is a method of magnetic alignment and crystallization of membrane proteins in two-dimensional (2D) sheets for protein structural characterization and applications in functional devices. Block co-copolymers are used in alternative embodiments to assist with the crystallization process.
Opening claim text (preview).
What is claimed is: 1. A method of forming a two-dimensional membrane protein crystal comprising: providing a solution containing a membrane protein and a block co-polymer; exposing the solution to a magnetic field to facilitate alignment of the membrane protein in the solution; and forming a membrane protein crystal from the solution, wherein the membrane protein crystal is formed in the presence of the magnetic field. 2. The method of claim 1 , wherein forming a membrane protein crystal from the solution comprises: concentrating the solution through dialysis. 3. The method of claim 1 , wherein a strength of the magnetic field is based on a diamagnetic anisotropy of the membrane protein. 4. The method of claim 1 , wherein a strength of the magnetic field is based on a diamagnetic anisotropy of the block co-polymer. 5. The method of claim 3 or 4 , wherein the diamagnetic anisotropy is estimated from a molecular simulation model. 6. The method of claim 3 or 4 , wherein the diamagnetic anisotropy is the sum of the diamagnetic anisotropy parallel to the magnetic field and the diamagnetic anisotropy perpendicular to the magnetic field. 7. The method of claim 1 , wherein a difference between a magnetic energy parallel to the magnetic field and a magnetic energy perpendicular to the magnetic field is greater than a thermal energy of the solution. 8. The method of claim 1 , wherein a mass fraction of the block co-polymer in the solution is less than 10%. 9. The method of claim 8 , wherein a diamagnetic anisotropy of the block co-polymer is larger than a diamagnetic anisotropy of the membrane protein. 10. A product created from the process of claim 1 . 11. A functional device incorporating a crystallized membrane protein comprising: a support layer having a plurality of pores; a membrane protein crystal formed in the presence of a magnetic field, wherein a diameter of the membrane protein crystal is larger than a diameter of the plurality of holes; and a bonding agent between the support layer and the membrane protein crystal. 12. The functional device of claim 11 , wherein the bonding agent is a functionalized group on at least one of the support layer and the membrane protein crystal.
Polyethylene · CPC title
Supported membranes; Membrane supports · CPC title
Flat membranes · CPC title
by deposition by filtration through a support or base layer · CPC title
Use of magnetic or electrical fields · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.